Program Objectives:

After attending this session, participants will be able to:

• Demonstrate timely identification of LR MDS and the optimal treatment of MDS-associated anemia
• Evaluate key decisions in the management of a patient with MDS while successfully navigating the digital MDS Clear Path tool
• Identify evidence-based support for decision points throughout the MDS treatment journey, as well as educational needs to be further addressed